Mepivacaine Accord

Mepivacaine, the active ingredient in Mepivacaine Accord, is a local anesthetic presented as a sterile solution for epidural, infiltration and perineural use. It provides reversible nerve impulse blockade to facilitate local anesthesia during surgical, dental and obstetric procedures in adult patients.

GNH USA supplies Mepivacaine Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality‑controlled batches and regulatory compliance for global distribution. The company adheres to EU GMP standards and provides comprehensive documentation to support import and clinical use.

Mepivacaine is a local anesthetic used to achieve reversible nerve blockade for a range of procedural indications.

- Surgical procedures: provides local anesthesia to facilitate operative interventions. - Dental surgery: enables painless tooth extractions and restorative work. - Epidural analgesia: delivers segmental pain relief during labor and postoperative periods. - Infiltration anesthesia: numbs targeted tissue for minor skin or soft‑tissue procedures. - Perineural nerve block: produces regional anesthesia for limb or trunk surgeries.

Mepivacaine may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Transient numbness or tingling at the injection site. - Mild dizziness or light‑headedness. - Temporary hypotension or mild bradycardia. - Localized swelling or mild erythema.

Serious or Rare Side Effects: - Seizures due to central nervous system toxicity. - Cardiac arrhythmias or conduction disturbances. - Severe allergic reactions, including anaphylaxis. - Respiratory depression or airway compromise.

When using Mepivacaine, clinicians should observe several safety measures.

- Assess patient medical history: identify cardiac disease, liver impairment, or known amide‑type anesthetic allergy. - Use caution in pregnancy: limited data, weigh benefits against potential risks. - Avoid intravascular injection: aspirate before administration and monitor for systemic signs. - Monitor vital signs: observe for signs of CNS or cardiovascular toxicity during and after dosing. - Store at ambient temperature: keep in original container, protect from light and moisture.

Mepivacaine can interact with other drugs, altering its safety profile.

Major Interactions (Avoid): - Class I antiarrhythmics (e.g., quinidine, procainamide): may potentiate cardiac toxicity. - Monoamine oxidase inhibitors (MAOIs): increase risk of severe hypertension.

Moderate Interactions (Monitor Closely): - Other local anesthetics: additive neuro‑ and cardiotoxic effects. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may enhance bleeding risk. - Opioids: synergistic CNS depression may occur.